keyboard_arrow_up

Cirrhosis Clinical Trials Market Review H1 2015

“Cirrhosis Global Clinical Trials Review, H1, 2015″ provides data on the Cirrhosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cirrhosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cirrhosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Inquire more about this report: http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=268948 .

This is a premium report priced at US$2500 for a single user PDF.


Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables

Cirrhosis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cirrhosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cirrhosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cirrhosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cirrhosis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cirrhosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Cirrhosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cirrhosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cirrhosis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cirrhosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cirrhosis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cirrhosis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cirrhosis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cirrhosis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cirrhosis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Cirrhosis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Cirrhosis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Cirrhosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Cirrhosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Cirrhosis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Cirrhosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Cirrhosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 35
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015* 38
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 39
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 40
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2015* 41
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015* 42
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 43
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 44
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 45
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 46
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 47
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 48
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, 2015* 49
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Govind Ballabh Pant Hospital, 2015* 50
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Liver and Biliary Sciences, 2015* 51
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 52
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Friendship Hospital, 2015* 53
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 54
Cirrhosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, 2015* 55